US HIV/AIDS Diagnostics Market Shares and Segment Forecasts 2023: HIV 1/2, Combo, Ag, NAT, Western Blot

July 2019 | 60 pages | ID: U7825AC9A45EN
Venture Planning Group

Abstracts

This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:

• Hospitals
• Commercial/Private Labs
• Blood Banks
• Public Health Labs
• Physician Offices

The DataPack provides sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche.

Contains 60 pages and 7 tables

Contents

Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
USA: HIV Ag Test Volume and Sales Forecast by Market Segment
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers